Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
RA Capital
Biotech
BMS-backed TORL grabs $158M to march army of ADCs through clinic
For companies exploring the antibody-drug conjugate arena, the interest from Big Pharma and big-pocketed investors appears to be as strong as ever.
James Waldron
Apr 10, 2024 9:35am
Diagonal launches with $128M to grow agonist antibody platform
Apr 3, 2024 6:00am
Eliem cuts in on Tango, proposing acquisition after review
Mar 19, 2024 10:57am
Boundless Bio bumps IPO market back to life
Mar 6, 2024 5:20pm
VC investment in biopharma dropped nearly $7B in 2023: PitchBook
Mar 5, 2024 5:00am
FogPharma clears $145M series E thanks to Borisy, ex-J&J CEO
Mar 1, 2024 9:55am